TREATMENT OF IMMUNOLOGICAL DISORDERS USING ANTI-CD30 ANTIBODIES

Details for Australian Patent Application No. 2002363939 (hide)

Owner SEATTLE GENETICS, INC.

Inventors LAW, Che-Leung; KLUSSMAN, Kerry; WAHL, Alan, F.; SENTER, Peter; DORONINA, Svetlana; TOKI, Brian

Pub. Number AU-A-2002363939

PCT Number PCT/US02/37223

PCT Pub. Number WO2003/043583

Priority 60/331,750 20.11.01 US

Filing date 20 November 2002

Wipo publication date 10 June 2003

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/331,750 20.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002363939

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363940-METHOD FOR ASSIGNING VARIABLE-LENGTH WALSH CODES FOR CODE DIVISION MULTIPLE ACCESS COMMUNICATIONS SYSTEMS

2002363938-METHODS AND USE OF MOTONEURONOTROPIC FACTORS